rs761966457
Variant summary
Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_014467.3(SRPX2):c.1238G>A(p.Arg413His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000339 in 1,209,214 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 24 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R413C) has been classified as Likely benign.
Frequency
Consequence
NM_014467.3 missense
Scores
Clinical Significance
Conservation
Publications
- rolandic epilepsy-speech dyspraxia syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- polymicrogyria, bilateral perisylvian, X-linkedInheritance: XL Classification: LIMITED Submitted by: G2P
- rolandic epilepsy, intellectual disability, and speech dyspraxia, X-linkedInheritance: XL Classification: LIMITED, NO_KNOWN Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -6 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| SRPX2 | ENST00000373004.5 | c.1238G>A | p.Arg413His | missense_variant | Exon 11 of 11 | 1 | NM_014467.3 | ENSP00000362095.3 | ||
| SRPX2 | ENST00000640282.1 | c.162G>A | p.Ser54Ser | synonymous_variant | Exon 3 of 3 | 5 | ENSP00000491188.1 | |||
| SRPX2 | ENST00000638920.1 | n.1241G>A | non_coding_transcript_exon_variant | Exon 10 of 10 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000180 AC: 2AN: 111003Hom.: 0 Cov.: 23 show subpopulations
GnomAD2 exomes AF: 0.0000874 AC: 16AN: 182996 AF XY: 0.000148 show subpopulations
GnomAD4 exome AF: 0.0000355 AC: 39AN: 1098211Hom.: 0 Cov.: 31 AF XY: 0.0000660 AC XY: 24AN XY: 363569 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000180 AC: 2AN: 111003Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 33227 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.1238G>A (p.R413H) alteration is located in exon 11 (coding exon 10) of the SRPX2 gene. This alteration results from a G to A substitution at nucleotide position 1238, causing the arginine (R) at amino acid position 413 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Rolandic epilepsy, intellectual disability, and speech dyspraxia, X-linked Uncertain:1
This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 413 of the SRPX2 protein (p.Arg413His). This variant is present in population databases (rs761966457, gnomAD 0.07%), and has an allele count higher than expected for a pathogenic variant. This variant has not been reported in the literature in individuals affected with SRPX2-related conditions. ClinVar contains an entry for this variant (Variation ID: 566880). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt SRPX2 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at